Embed Size (px)
Citation preview
BIOCENTURYBIOCENTURY
BIOCENTURY’S SUBSCRIBER AUDIENCE
Research
Finance
Big Corporate Biopharma
Small CorporateBiopharma
9%
31%
24%
36%
By Company
Put your company in front of C-level biopharma executives and investors.
For over 25 years, BioCentury has helped C-level biotech executives and global investors make business-critical decisions by providing independent deep-dive analysis, high-quality data, and business intelligence on a global scale. We report on and dissect trends before others, helping you to better position your company for change and to capitalize on that change before your competition. When you subscribe to BioCentury, our team of PhDs, analysts, and industry experts become an extension of your team to help you answer critical questions, decipher strategic trends, objectively evaluate product and business strategies, and assess competitive, financial, and policy risks. We also help you to build your network by connecting you to industry KOLs in the U.S., Europe, Japan, China and around the world.
Company Overview
BIOCENTURY
www.BioCentury.com
BIOCENTURY.COM is an intelligence platform that provides timely analysis about the global life science industry.
Gain exposure on BioCentury’s website and benefit from a global audience of biopharma industry decision makers and investors and more.
• 125,000 visitors per month• 300,000 page views per month• More than 300,000 ad impressions per month• 46% of site visitors are from outside of North America
Banner Advertising Options:Position Weekly RateLeaderboard 728x90...........................................................................................................................................................$1,500Skyscraper 300x600...........................................................................................................................................................$1,000Medium Rectangle 300x250............................................................................................................................................$1,000Medium Rectangle 300x250............................................................................................................................................$1,000
BIOCENTURY
• Product Development• Emerging Companies• Targets & Mechanisms • Tools & Techniques • Regulation
• Politics, Policy & Law• Deals• Finance• Translation in Brief • Management Tracks
BioCentury Weekly and Distillery
BioCentury’s industry leading analysis
BIOCENTURY DAILY is published every business day and emailed to all subscribers. BioCentury Daily includes ALL the analysis we published over the last business day, by topic. Perfect for reading on mobile phones, the scrollable format allows you to zip through headlines and choose the stories you want to read
BIOCENTURY WEEKLY is distributed to all subscribers and provides a roundup of our deep-dive analysis for the week to ensure you don’t miss the most important intelligence from our editorial team. Delivered every Friday night, it is organized by topic, allowing you to easily scroll and select the articles you want to read.
Leaderboard640 x 100
Mid-placement640 x 100
Leaderboard640 x 100
Mid-placement640 x 100
BioCentury Daily
Feature sections include:
640x100 static gif leaderboard + 65 word text ad..................$3,500/5 days640x100 static gif mid-placement ad..........................................$2,000/5 days
Banner Advertising Options
640x100 static gif leaderboard + 65 word text ad..........................................................................$1,100/Friday Issue640x100 static gif mid-placement ad.....................................................................................................$750/Friday Issue
Banner Advertising Options
THE BIOCENTURY DISTILLERY is published monthly and emailed to all subscribersproviding a quick way to find discovery breakthroughs with commercial potential. It also prioritizes new therapeutics, targets, pathways, mechanisms and compounds that have not yet entered clinical testing or been disclosed in company pipelines. You can access this content anytime, anywhere as part of our newly integrated intelligence platform at BioCentury.com.
Leaderboard640 x 100
Mid-placement640 x 100
BIOCENTURY
Sponsored Emails
With a comprehensive database of more than 25,000 senior-level biopharma executives and investors, BioCentury offers you access to executives and decision makers in the industry. BioCentury’s production team will send out an html email message on your behalf to a select targeted audience. Your custom message will be embedded into BioCentury’s sponsored email broadcast template and will drive traffic back to your website or content.
Price per email begins at $4,000
BIOCENTURY
eLearningThis library hosts valuable papers that provide technical information on new and existing products, applications, and techniques submitted by the Biopharm Industry’s leading providers. BioCentury invites readers to download these whitepapers at no charge after providing some short contact information. In addition, sponsors will have access to download data containing all leads provided monthly by BioCentury.
BioCentury will host your whitepaper in the E-LEARNING CENTER on BioCentury.com for six months and generate new leads based on download activity.
BioCentury White Papers
Price per Whitepaper..................................................................................... $2,500/6 monthsWhitepaper promotion options available at additional cost.
BIOCENTURY
BioCentury Collections
BioCentury will work with you to assemble a collection of articles that are relevant to your company including cutting edge technologies and innovative ideas that are shaping the biopharma industry. You can choose from 25 years of archived content from BioCentury for your custom sponsored collection that includes design, a one page company profile and distributed via pdf to BioCentury’s audience via email which includes over 25,000 leaders in the life sciences.
Promotion options available at additional cost.
BIOCENTURY
Emerging Company Profiles Sponsorship
This year BioCentury will cover more than 90 EMERGING COMPANY PROFILES that are included in our weekly publication. This sponsorship includes a monthly email distributed to our subscribers highlighting that month’s profiles with sponsor recognition and messaging. The sponsor can then take the email and use it to distribute to their existing audience as well providing new content to share with clients and prospects on a monthly basis. This sponsorship can also be used through social media to link back to the featured content.
Sponsorship is available quarterly for $12,000Promotion options available at additional cost.
BIOCENTURY
BioCentury ConferencesEurope
Bio€quity Europe Overview: Now celebrating its 21st meeting in Dublin, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 800 leading European companies to thousands of investment and pharma business development professionals. Delegates from over 27 countries attended Bio€quity Europe last year in Barcelona.
Bio€quity Europe 2019 Highlights (Barcelona):
More than 150 VCs from the leading venture capital firms.
More than 250+ biopharma executives, many of them CEOs/CFOs. Of the presenting companies, 50 werefull presenting companies and 25 of them were ‘Next Wave’ presenters, and 10 were ‘pre-seed’ companies representing great access to newly formed private companies from Europe.
Bio€quity Europe 2019 in Numbers (Barcelona):
• 600+ delegates• 2,000+ scheduled one-to-one meetings• 95 company presentations• 27 countries represented
Bio€quity Europe 2019 Attendance Breakdown:
“Bio€quity Europe is a ‘must go’ for both VCs and CEOs of life science companies in Europe … it is THE event where you can feel the pulse of the industry…”
- Antoine Papiernik,Managing Partner, Sofinnova Partners
Consulting/Service Provider/Law
Pharma
Biotech
Sponsorship Opportunities
Gold Sponsor..................................................€25,000Silver Sponsor.................................................€15,000
PharmaOther
BIOCENTURY
BioCentury ConferencesChinaChina Summit Overview: BioCentury and BayHelix Present: The 7th China Healthcare Summit. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting. The China Summit will include:
• Strategic Sessions: 2+ days of tailored content to help busy executives understand emerging opportunities and challenges in China.
• Exclusive Report: The China Summit report created by Insights Partner, McKinsey & Company. This exclusive analysis documents market trends and identifies business imperatives for biopharma and MedTech companies doing business in China.
• Road Show Presentations: Includes 45+ biotech and MedTech companies from China, Asia and the West, hand-picked by BioCentury and BayHelix.
• 1x1 Meeting System: Attendees can arrange face-to-face discussions with investors and corporate delegates over 2 full days.
• BayHelix Awards Lunch Banquet: An annual celebration of R&D and commercial achievements in China.• VIP Receptions: Network with senior-level executives and investors at the Monday night Welcome
Reception and the Gala Dinner on Tuesday.• New for 2020 - China Summit MedTech Day: A full day MedTech Track, featuring strategic panels, keynotes
and presenting companies
BioCentury China Summit 2019 Attendance Breakdown:
Sponsorship Opportunities
Platinum Sponsorship..................................$25,000Session Sponsorship.....................................$17,500Networking Break Host.................................$8,500 Silver Domestic Sponsorship......................$6,000
BioCentury China Summit 2019 Highlights:• 700 senior-level executives and investors from China, Asia and the West, including delegates from 20
countries. • 18 strategic panels and keynotes• Exclusive conference report prepared by McKinsey & Co.• 10th BayHelix China Healthcare Awards Ceremony to honor outstanding contributions to the local
healthcare ecosystem• 900+ scheduled one-to-one meetings
Western/MNCBiopharma
China/Asia Biopharma
CROs/Consultancies
AcademicDevice/Tool/Genomics
Investors
7th China Healthcare SummitNovember 9-11, 2020 | Shanghai, China
BIOCENTURY
Distillery Networking Reception
BioCentury’s Distillery Reception is the place to “see and be seen” amongst the C-level biopharma executives and investment decision makers attending JPMorgan. Our 2020 event convened more than 1,000 executives and investment professionals for a relaxing evening of networking with hand selected, single malt selections from around the world. For 2021 we will return to the Mezzanine (night club), housed in a historic two-story warehouse. The Mezzanine features large expanses of unobstructed wall space, soaring ceilings and immense skylights.
BioCentury partners with sponsors to offer your team the ability to co-host the event and invite your VIP’s to an established reception while we manage all of the logistics, invites and follow up. All you have to do is invite your guests and we take care of the rest.
Affordable sponsorship packages are available for the Distillery and allow BioCentury to highlight your company to our top notch audience.
Gold Reserve Sponsorship........................................................$17,500
Premium Sponsorship.................................................................$12,500
Sponsor benefits include:
• Unlimited team access to the Reception• Ability to invite 75 (premium) or 150 (gold reserve) VIPs
to attend• Custom sponsor lounge for gold reserve sponsors• Inclusion in the branding and marketing for the event• Recognition in all of the VIP invitations and onsite with
ample signage and gobo lighted logo• Ability to distribute collateral at the event• Ability to distribute party giveaways
BIOCENTURY
BioCentury Executive Networking Dinners
BioCentury Executive Networking Dinners bring together an invitation-only group of biotech C-suite, top investors and academic KOLs for an evening of discussion and networking in an intimate setting. These dinners, held in biotech hot spots like Boston/Cambridge, provide sponsors with exclusive branding and access to decision-makers across the innovation ecosystem.
WELCOME TO THE INAUGURAL
BioCentury Dinner with C-Level Executives
BioCentury Dinner With C-Level Executives
Thursday, December 12, 2019 at 6:30pm
Price: $15,000
BIOCENTURY
Lam Lu, Head/Business Intelligence Group
BUSINESS SERVICES
Accounting & Billing: [email protected]
Conferences: [email protected]
Data Solutions Support: [email protected]
Privacy Policy: [email protected]
Reprints/Permissions: [email protected]
PRIVACY & ADVERTISINGIn accordance with its Privacy Policy, BioCentury does NOT sell its customer information or usage data to third parties. BioCentury does NOT sell advertising in the BioCentury, BioCentury Innovations or BioCentury Week in Review publica-tions. BioCentury is pleased to acknowl edge its conference partners and sponsors through promotional announcements in its publi cations. BioCentury MAY accept paid promotional mes-sages from sponsors, which are displayed only on BioCentury’s websites and in BioCentury Extra.
Administration & Human Resources
BUSINESS DEVELOPMENT
Joshua Berlin, Executive Director
Juli Balestrieri, Kevin Lehnbeuter, Business Development Managers
PRODUCT MANAGEMENT & MARKETING
Greg Monteforte, Director/ Marketing & Promotional Services
Josephine Asciutto-Bunn, Marketing Coordinator
SUBSCRIBER SERVICES
Tim Tulloch, Senior Director
Orlando Abello, Matt Krebs, Michelle Ortega, Ron Rabinowitz, Account Managers
Hannibal Adofo, Marilyn Smith, Subscriber Services
TECHNOLOGY
Jenny Nichols, Director/Publishing
BioCentury’s mission is to provide value-added business intelli-gence & analysis for life science companies, investors, academia and government on the strategic issues essential to the forma-tion, development and sustainability of life science ventures.
BioCentury Inc.BioCentury International Inc.
MAIN OFFICES1235 Radio Road, Ste. 100 Redwood City, CA 94065-1217 +1 650-595-5333; Fax: +1 650-595-5589
CORPORATE
Karen Bernstein, Ph.D., Co-Founder & Chairman
David Flores, Co-Founder, President & CEO
C. Simone Fishburn, Ph.D., Vice President/Editor in Chief
Adam Gordon: Vice President/ Product Management & Marketing
David Smiling: Chief Technology Officer
Bennet Weintraub: Vice President/ Administration & CFO
Eric Pierce: Publisher
Susan Morgan: Senior Director/
CORPORATE, SUBSCRIPTIONS & PRIVACY
USE OF IMAGES: Certain Images used in BioCentury Inc.’s Publications, Video Content, Websites, Services, Notices and/or Marketing Materials are licensed from Getty Images (US), Inc. Any such image of a person or object so displayed is being used for illustrative purposes only and any such person or object depicted, if any, is merely a model. For more information see “Use of Images” found under the “Legal” section on the footer of the homepage at www.biocentury.com.
BioCentury®; Because Real Intelligence is Hard to Find™; BCIQ™; The BioCentury 100™; and The Clear Route to ROI™ are trademarks of BIOCENTURY INC. All contents Copyright © 2020, BIOCENTURY INC. ALL RIGHTS RESERVED. No part of BioCentury’s Publications or Website may be copied, repro-duced, retransmitted, disseminated, sold, distributed, published, broadcast, circulated, commercially exploited in any form or used to create derivative works without the written consent of BioCentury. Information provided by BioCentury’s Publica-tions and Website is gathered from sources that BioCentury believes are reliable; however, BioCentury does not guarantee the accuracy, completeness, or timeliness of the information, nor does BioCentury make any warranties of any kind regarding the information. The contents of BioCentury’s Publications and Website are not intended as investment, business, tax or legal advice, and BioCentury is not responsible for any investment, business, tax or legal opinions cited therein or for any decision made or action taken in reliance upon such information.
All use of BioCentury and its contents by current subscribers is governed by the BioCentury User Agreement and by all others is governed by the BioCentury Terms of Use, unless a written agreement to the contrary has been executed by BioCentury Inc.
Jeff Cranmer, Selina Koch, Ph.D., Executive Editors
Steve Usdin, Senior Editor/Washington & Head: Policy & Regulation
Lauren Martz, Senior Editor, Head of Translation & Clinical Development
Karen Tkach Tuzman, Ph.D., Associate Editor & Head: Discovery and Preclinical Development
Paul Bonanos, Stephen Hansen, Virginia Li, Inhua Muijrers-Chen, Ph.D., Karen Tkach Tuzman, Ph.D., Associate Editors
Meredith Durkin Wolfe, Winnie Pong, Ph.D., Associate Editors, Data & Analytics
Sandi Wong, Ph.D., Assistant Editor
Allison Johnson, Ph.D., Senior Writer
Elizabeth S. Eaton, Hongjiang Li, Ph.D., Claire Quang, Staff Writers
C. Simone Fishburn, Ph.D., Editor in Chief
Editors Emeritus: Susan Schaeffer (2012-2018); Karen Bernstein, Ph.D. (1992-2012)
BioCentury Innovations: Idea to IND
BioCentury: Phase I to the Patient
BioCentury Extra: Essential News for Biotech and Pharma
NEWSROOM: [email protected]
SAN CARLOS, CA: +1 650-595-5333
CHICAGO: +1 312-755-0798
WASHINGTON, DC: +1 202-462-9582
UNITED KINGDOM: +44 (0)1865-512184
EDITORIAL & RESEARCH
